Spruce Biosciences Newsroom

Spruce Biosciences Analyst Ratings

BenzingaNov 12 22:56

RBC Capital Maintains Spruce Biosciences(SPRB.US) With Hold Rating, Maintains Target Price $2

Futu NewsNov 12 20:36

RBC Capital Sticks to Their Hold Rating for Spruce Biosciences (SPRB)

TipRanksNov 12 19:45

JMP Securities Maintains Spruce Biosciences(SPRB.US) With Buy Rating, Maintains Target Price $3

Futu NewsSep 11 13:31

JMP Securities Maintains Spruce Biosciences(SPRB.US) With Buy Rating, Maintains Target Price $3

Futu NewsSep 11 09:32

Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Spruce Biosciences (SPRB) and Envista Holdings (NVST)

TipRanksAug 20 15:05

Spruce Biosciences Analyst Ratings

BenzingaAug 19 20:30

Analysts' Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and ScPharmaceuticals (SCPH)

TipRanksAug 19 18:34

H.C. Wainwright Maintains Spruce Biosciences(SPRB.US) With Hold Rating

Futu NewsAug 19 18:31

RBC Capital Reiterates Sector Perform on Spruce Biosciences, Maintains $2 Price Target

BenzingaAug 14 00:30

Spruce Biosciences Analyst Ratings

BenzingaAug 14 00:29

RBC Capital Maintains Spruce Biosciences(SPRB.US) With Hold Rating, Maintains Target Price $2

Futu NewsAug 13 19:33

Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS)

TipRanksAug 13 18:54

Buy Rating Affirmed for Spruce Biosciences Amid Anticipated Positive Clinical Trial Outcomes and Strong Financial Position

TipRanksAug 13 12:20

JMP Securities Maintains Spruce Biosciences(SPRB.US) With Buy Rating, Maintains Target Price $3

Futu NewsJul 26 12:32

Spruce Biosciences Analyst Ratings

BenzingaJun 13 19:58

Spruce Biosciences Analyst Ratings

BenzingaJun 5 19:25

Hold Rating on Spruce Biosciences Amid Clinical Trial Uncertainties and Rising Competition

TipRanksMay 16 16:15

Buy Rating Affirmed for Spruce Biosciences Amid Upcoming Trial Data and Strong Financial Position

TipRanksMay 15 06:50

Spruce Biosciences Analyst Ratings

BenzingaMay 14 18:25